Professional Media briefs

Share this article:
Quadrant HealthCom's The Female Patient launched a new website at femalepatient.com. The site features a new look, easier navigation and access to audiocasts, videocasts and mobile apps, along with an improved registration/subscription process allowing users to customize, change and update preferences.

Thomson Reuters acquired GeneGo, a San Diego-based firm that provides biology and disease information, analytics and decision support services for pharma R&D. GeneGo will be folded into Thomson Reuters' Healthcare & Science business. The acquisition bolsters Thomson Reuters' drug pipeline competitive intelligence, patents and chemistry offerings with GeneGo's expertise in science, particularly on biologics. In addition to its San Diego headquarters, GeneGo has offices in Moscow and Michigan.

Elsevier dropped the “Cytogenetics” from its Cancer Genetics and Cytogenetics journal, and tapped a new editor-in-chief. The first issue with the shortened title, Cancer Genetics, goes out this month, with Jaclyn Biegel at the helm. The title change reflects a broader aim and scope for the journal, with a new focus on diagnostic applications and genetic predisposition of cancer, according to a statement.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?